AI in antibody discovery: Why better data still matters
AI and machine learning are becoming increasingly important in antibody discovery, but the field is moving beyond the idea that computational tools will simply replace experimental science.
Rethinking ‘Diversity’ and ‘Inclusion’ as Everyday Leadership Skills: Moving beyond initiatives to real-world leadership practice
Leadership today is less about having the right answers and more about navigating complexity. Decisions are made with incomplete information, competing priorities, and constant pressure to move quickly. No leader sees the full picture alone.
What organisations should consider before digitising legacy video media
Many organisations still hold valuable video content recorded on legacy formats such as VHS, Hi8, and MiniDV. These recordings may document training, research activity, events, or internal communications that are no longer reproducible.
VHH bolt-ons: Modular building blocks for smarter biologics
VHH single-domain antibodies are increasingly being used as modular building blocks in next-generation biologics.
Whitepaper: Validating synthetic VHH libraries for therapeutic discovery
Synthetic VHH libraries are becoming an increasingly important route for antibody discovery, offering a faster, more controlled alternative to traditional immunisation-based workflows.
Antibody discovery and IP risk: Why freedom to operate matters earlier than you think
In antibody discovery, identifying a promising binder is only part of the challenge. For well-established targets, companies also need to consider whether the resulting sequences are novel, patentable and commercially usable.
Unlocking hard-to-drug targets with VHH antibody discovery
Many high-value therapeutic targets remain difficult to drug, particularly where targets are intracellular, conformationally complex, poorly accessible, highly conserved or embedded in membrane environments.
NGS in antibody discovery: Why sequence depth matters
Next-generation sequencing is changing how antibody discovery teams understand library performance, selection outputs and candidate diversity.
Why Cambridge UK remains a global hub for antibody discovery
Cambridge UK has long been one of the world’s most important centres for life sciences, translational research and biotechnology innovation.
Top 3 tips to ensure you don’t miss out on top talent
By Hayley Murfitt, Director, EA First
Why copying the best might be your worst strategy
By Jonathan Pearce, Co-Founder & Principal Consultant at Alignment Cubed.
Celebrating over 500,000 patients treated with the Sentimag platform
The Sentimag® platform has officially helped over 500,000 patients to access a better standard of breast cancer care
Over many years of being in and around operating rooms across the world, we’ve seen the trauma that a breast cancer diagnosis can bring.